Le Lézard
Classified in: Science and technology
Subject: Product/Service

Forcura Launches Referral Summary for Post-Acute Care Market


Forcura, a healthcare workflow management company, today announced that it has released a new feature that instantly summarizes a patient referral packet and presents essential referral criteria in a concise, shareable format. The summary represents Forcura's first deployment of generative artificial intelligence in its cloud-based workflow platform.

Typically, referral packets which can number hundreds of pages are delivered to home-based care agencies and other post-acute organizations via disparate, paper-based methods. Post-acute care clinicians and back-office staff must manually identify and aggregate vital patient information including patient demographics, clinical condition, services ordered, certifying physician, payer and referral source and determine which patients they can accept into care. This time-consuming process frequently creates a bottleneck for acute-care facilities who are waiting to discharge patients and can increase a patient's hospital readmission risk if they've already been discharged and are awaiting care at home. This administrative burden further strains short-staffed post-acute teams and detracts from the time they'd prefer to spend with patients.

Forcura's platform solves that referral bottleneck with technology that transforms the intake process. Users manage all referrals from a single, digital inbox and efficiently move through a workflow that automates data capture with its Referral IQ product. Referral summary is a new feature of the Referral IQ product and uses HIPAA-compliant generative AI to present all the most pertinent referral information in a consumable format. Consequently, users can quickly and confidently make their intake decisions, alleviating bottlenecks for their referral partners and accelerating their speed to patients needing care.

Early adopters of referral summary include members of Forcura's client advisory board, which provided strategic direction for referral summary and offered numerous use cases that could improve patient care planning, coding and communication with referral partners. Reliant at Home has since joined the advisory board. Reliant's chief operating officer, Jana Lightfoot, said of the referral summary,

With Forcura's referral summary, we're able to hit two company priorities: deliver care to patients as quickly as possible and make life easier for our field staff. Referral summary saves precious time on the front-end during the intake process and allows us to begin care coordination planning in a matter of moments. Additionally, because the referral summary attaches as the first page of the referral packet, it paints a single-view picture for the admitting clinician, so they know why we are providing care, the patient's clinical history, and any other clinical findings that might be buried deep in the referral file.

"GenAI has tremendous implications on improving patient care transitions and coordination. It will empower our clients to make faster, better decisions about accepting patients into their care," states Craig Mandeville, Forcura's founder and CEO. "I'm proud that our team quickly embraced this new tech and brought referral summary to market in rapid time." Craig concludes, "We know that referral summary is just the beginning of how we'll leverage GenAI, and we can't wait to provide more cutting-edge solutions that improve our clients' performance and their patient outcomes."

About Forcura

Forcura, a healthcare workflow management company headquartered in Jacksonville, Florida, facilitates continuity of care and improves business performance for providers via its automated workflow, collaboration and analytics SaaS solutions. The company is deeply committed to empowering better patient care and elevating the role of post-acute in the broader healthcare continuum. The company is a 2024 Best in KLAS® Winner, is a certified Great Place to Worktm employer, and has ranked for the seventh consecutive year on the Inc. 5000. For more information visit forcura.com, call 800-378-0596 or follow Forcura on LinkedIn.


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: